Literature DB >> 1894587

Valproate in combat-related posttraumatic stress disorder.

F A Fesler1.   

Abstract

BACKGROUND: The symptoms of posttraumatic stress disorder (PTSD) suggest sympathetic nervous system hyperarousal and hyperreactivity. Pathophysiology of this condition may include stress-activated limbic kindling. Antikindling agents lithium and carbamazepine have been found effective for PTSD symptoms of intrusive reexperiencing and increased arousal. These facts suggest that valproate, another drug shown to interfere with limbic kindling, could also be effective for treatment of PTSD.
METHOD: An open clinical trial of valproate was conducted in 16 Vietnam veterans diagnosed with DSM-III-R combat-related PTSD.
RESULTS: Ten of 16 patients showed significant improvement, especially in hyperarousal/hyperreactivity symptoms.
CONCLUSIONS: The efficacy of valproate in the treatment of PTSD should be rigorously studied.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894587

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  27 in total

Review 1.  Post-traumatic stress disorder: a review of recent findings.

Authors:  S Seedat; M B Stein
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 2.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

Review 3.  Comorbidity in pediatric bipolar disorder.

Authors:  Gagan Joshi; Timothy Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

Review 4.  Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

Authors:  William Berger; Mauro V Mendlowicz; Carla Marques-Portella; Gustavo Kinrys; Leonardo F Fontenelle; Charles R Marmar; Ivan Figueira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-12-24       Impact factor: 5.067

5.  Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.

Authors:  Kathryn M Connor; Jonathan R T Davidson; Richard H Weisler; Wei Zhang; Kurian Abraham
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

Review 6.  PTSD diagnosis and treatment for mental health clinicians.

Authors:  M J Friedman
Journal:  Community Ment Health J       Date:  1996-04

Review 7.  Post-traumatic stress disorder in children and adolescents: epidemiology, diagnosis and treatment options.

Authors:  Craig L Donnelly; Lisa Amaya-Jackson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuse.

Authors:  Joseph F Goldberg; Marylene Cloitre; Joyce E Whiteside; Hyemee Han
Journal:  Curr Ther Res Clin Exp       Date:  2003-01

9.  Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial.

Authors:  Hans Steiner; Kirti S Saxena; Victor Carrion; Leena A Khanzode; Melissa Silverman; Kiki Chang
Journal:  Child Psychiatry Hum Dev       Date:  2007-06-15

10.  Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.

Authors:  Seth D Norrholm; Tanja Jovanovic
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.